Compare MAPS & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAPS | FORA |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | 449 | N/A |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.7M | 66.2M |
| IPO Year | N/A | 2020 |
| Metric | MAPS | FORA |
|---|---|---|
| Price | $0.64 | $2.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.61 | N/A |
| AVG Volume (30 Days) | ★ 686.2K | 14.5K |
| Earning Date | 03-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,256,919.00 |
| Revenue This Year | N/A | $51.82 |
| Revenue Next Year | $6.17 | $7.24 |
| P/E Ratio | $9.75 | ★ N/A |
| Revenue Growth | N/A | ★ 50.13 |
| 52 Week Low | $0.60 | $1.64 |
| 52 Week High | $1.36 | $2.71 |
| Indicator | MAPS | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 49.45 |
| Support Level | N/A | $2.04 |
| Resistance Level | $0.88 | $2.12 |
| Average True Range (ATR) | 0.04 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 16.07 | 64.71 |
WM Technology Inc operates an online cannabis marketplace for consumers, together with a comprehensive set of e-commerce and compliance software solutions for cannabis businesses, which are sold to both storefront locations and delivery operators (retailers) and brands in the legalized cannabis markets in states and territories of the United States. Its comprehensive business-to-consumer and business-to-business suite of products affords cannabis retailers and brands of all sizes integrated tools to compliantly run their businesses and to reach, convert, and retain consumers.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.